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Gut bacteria are processing food, but also herbal medicinal products, and produce 
signalling molecules that regulate appetite, satiety, and digestion, but also other body 
functions. Dysbiosis of gut microbiota can contribute to systemic inflammation, it can 
lead to obesity, asthma, diabetes, autoimmune diseases, and even to certain forms of 
cancer. Therefore, herbal extracts certainly modulate our health by influencing the gut 
ecosystem [1,2]. 
In our research platform, predigestion is conducted in a static in-vitro model, according 
to the InfoGest consensus method. Subsequently extracts are incubated with human 
fecal suspension under anaerobic physiological conditions. Samples are taken at time 
points 0.5 h, 4 h, and 24 h. Changes in the composition of plant extracts are monitored 
by LC-HRMS. Microbiome shifts are tracked by 16S RNA sequencing.  
Microbial degradation of many classes of compounds has been observed during 
incubation of various herbal extracts with human fecal suspension. Flavonoid 
glycosides and aglycones, procyanidins, salicylic alcohol derivatives, caffeic acid 
derivatives, and triterpene glycosides, are rapidly and intensively metabolized. 
Numerous newly formed compounds could be assigned to putative microbial 
metabolites [3]. 
In conclusion, the combined LC-HRMS and next-generation sequencing approach 
allows straightforward detection of relevant microbiome shifts and metabolites. The 
role of the metabolites as active principles urgently needs to be investigated. 
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